{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:45:37Z","timestamp":1790696737514,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2015,8,18]],"date-time":"2015-08-18T00:00:00Z","timestamp":1439856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1245\/s10434-015-4813-8","type":"journal-article","created":{"date-parts":[[2015,8,17]],"date-time":"2015-08-17T12:14:48Z","timestamp":1439813688000},"page":"714-720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma"],"prefix":"10.1245","volume":"22","author":[{"given":"Kei","family":"Satoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaval","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Dieckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naris","family":"Nilubol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Electron","family":"Kebebew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,18]]},"reference":[{"key":"4813_CR1","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00268-005-0329-x","volume":"30","author":"E Kebebew","year":"2006","unstructured":"Kebebew E, Reiff E, Duh QY, Clark OH, McMillan A. Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg. 2006;30:872\u20138.","journal-title":"World J Surg."},{"key":"4813_CR2","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1210\/jc.2008-2291","volume":"94","author":"SH Golden","year":"2009","unstructured":"Golden SH, Robinson KA, Saldanha I, Anton B, Ladenson PW. Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab. 2009;94:1853\u201378.","journal-title":"J Clin Endocrinol Metab."},{"key":"4813_CR3","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1002\/1097-0142(19931201)72:11<3145::AID-CNCR2820721105>3.0.CO;2-N","volume":"72","author":"MD Wooten","year":"1993","unstructured":"Wooten MD, King DK. Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Cancer. 1993;72:3145\u201355.","journal-title":"Cancer."},{"key":"4813_CR4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<711::AID-CNCR1>3.0.CO;2-W","volume":"88","author":"BL Wajchenberg","year":"2000","unstructured":"Wajchenberg BL, Albergaria Pereira MA, Medonca BB, et al. Adrenocortical carcinoma: clinical and laboratory observations. Cancer. 2000;88:711\u201336.","journal-title":"Cancer."},{"key":"4813_CR5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1055\/s-2006-923808","volume":"114","author":"AC Koschker","year":"2006","unstructured":"Koschker AC, Fassnacht M, Hahner S, Weismann D, Allolio B. Adrenocortical carcinoma\u2014improving patient care by establishing new structures. Exp Clin Endocrinol Diabetes. 2006;114:45\u201351.","journal-title":"Exp Clin Endocrinol Diabetes."},{"key":"4813_CR6","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM199004263221705","volume":"322","author":"JP Luton","year":"1990","unstructured":"Luton JP, Cerdas S, Billaud L, et al. Clinical features of adrenocortical carcinoma, prognostic factors, and the effect of mitotane therapy. N Engl J Med. 1990;322:1195\u2013201.","journal-title":"N Engl J Med."},{"key":"4813_CR7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/eje.0.1490273","volume":"149","author":"L Barzon","year":"2003","unstructured":"Barzon L, Sonino N, Fallo F, Palu G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol. 2003;149:273\u201385.","journal-title":"Eur J Endocrinol."},{"key":"4813_CR8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0022-5347(05)67888-3","volume":"163","author":"L Barzon","year":"2000","unstructured":"Barzon L, Boscaro M. Diagnosis and management of adrenal incidentalomas. J Urol. 2000;163:398\u2013407.","journal-title":"J Urol."},{"key":"4813_CR9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.beem.2008.10.008","volume":"23","author":"M Fassnacht","year":"2009","unstructured":"Fassnacht M, Allolio B. Clinical management of adrenocortical carcinoma. Best Pract Res Clin Endocrinol Metab. 2009;23:273\u201389.","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"4813_CR10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00268-001-0047-y","volume":"25","author":"P Icard","year":"2001","unstructured":"Icard P, Goudet P, Charpenay C, et al. Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons Study Group. World J Surg. 2001;25:891\u20137.","journal-title":"World J Surg."},{"key":"4813_CR11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0025-7125(03)00149-4","volume":"88","author":"ED Vaughan Jr","year":"2004","unstructured":"Vaughan ED, Jr. Diseases of the adrenal gland. Med Clin North Am. 2004;88:443\u201366.","journal-title":"Med Clin North Am."},{"key":"4813_CR12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s00268-012-1802-y","volume":"37","author":"L Tessonnier","year":"2013","unstructured":"Tessonnier L, Ansquer C, Bournaud C, et al. (18)F-FDG uptake at initial staging of the adrenocortical cancers: a diagnostic tool but not of prognostic value. World J Surg. 2013;37:107\u201312.","journal-title":"World J Surg."},{"key":"4813_CR13","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1200\/JCO.20.4.941","volume":"20","author":"A Stojadinovic","year":"2002","unstructured":"Stojadinovic A, Ghossein RA, Hoos A, et al. Adrenocortical carcinoma: clinical, morphologic, and molecular Characterization. J Clin Oncol. 2002;20:941\u201350.","journal-title":"J Clin Oncol."},{"key":"4813_CR14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2006-0706","volume":"92","author":"G Assie","year":"2007","unstructured":"Assie G, Antoni G, Tissier F, et al. Prognostic parameters of metastatic adrenocortical carcinoma. J Clin Endocrinol Metab. 2007;92:148\u201354.","journal-title":"J Clin Endocrinol Metab."},{"key":"4813_CR15","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1507\/endocrj.K07-079","volume":"55","author":"R Morimoto","year":"2008","unstructured":"Morimoto R, Satoh F, Murakami O, et al. Immunohistochemistry of a proliferation marker Ki67\/Mib1 in adrenocortical carcinomas: Ki67\/Mib1 labeling index is a predictor for recurrence of adrenocortical carcinomas. Endocr J. 2008;55:49\u201355.","journal-title":"Endocr J."},{"key":"4813_CR16","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1200\/JCO.2008.18.5678","volume":"27","author":"A Reynies de","year":"2009","unstructured":"de Reynies A, Assie G, Rickman DS, et al. Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival. J Clin Oncol. 2009;27:1108\u201315.","journal-title":"J Clin Oncol."},{"key":"4813_CR17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/jso.23015","volume":"105","author":"NM Datrice","year":"2012","unstructured":"Datrice NM, Langan RC, Ripley RT, et al. Operative management for recurrent and metastatic adrenocortical carcinoma. J Surg Oncol. 2012;105:709\u201313.","journal-title":"J Surg Oncol."},{"key":"4813_CR18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40134-013-0016-x","volume":"1","author":"J Czernin","year":"2013","unstructured":"Czernin J, Allen-Auerbach M, Nathanson D, Herrmann K. PET\/CT in oncology: current status and perspectives. Curr Radiol Rep. 2013;1:177\u201390.","journal-title":"Curr Radiol Rep."},{"key":"4813_CR19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12672-011-0091-5","volume":"2","author":"D Deandreis","year":"2011","unstructured":"Deandreis D, Leboulleux S, Caramella C, Schlumberger M, Baudin E. FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma. Horm Cancer. 2011;2:354\u201362.","journal-title":"Horm Cancer."},{"key":"4813_CR20","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1210\/jc.2005-2612","volume":"91","author":"GC Mackie","year":"2006","unstructured":"Mackie GC, Shulkin BL, Ribeiro RC, et al. Use of [18f]fluorodeoxyglucose positron emission tomography in evaluating locally recurrent and metastatic adrenocortical carcinoma. J Clin Endocrinol Metab. 2006;91:2665\u201371.","journal-title":"J Clin Endocrinol Metab."},{"key":"4813_CR21","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/jc.2005-1540","volume":"91","author":"S Leboulleux","year":"2006","unstructured":"Leboulleux S, Dromain C, Bonniaud G, et al. Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography. J Clin Endocrinol Metab. 2006;91:920\u20135.","journal-title":"J Clin Endocrinol Metab."},{"key":"4813_CR22","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1210\/jc.2008-2302","volume":"94","author":"L Groussin","year":"2009","unstructured":"Groussin L, Bonardel G, Silvera S, et al. 18f-fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J Clin Endocrinol Metab. 2009;94:1713\u201322.","journal-title":"J Clin Endocrinol Metab."},{"key":"4813_CR23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1148\/radiol.11100569","volume":"259","author":"GW Boland","year":"2011","unstructured":"Boland GW, Dwamena BA, Jagtiani Sangwaiya M, et al. Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology. 2011;259:117\u201326.","journal-title":"Radiology."},{"key":"4813_CR24","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1007\/s00268-011-1374-2","volume":"36","author":"L Gust","year":"2012","unstructured":"Gust L, Taieb D, Beliard A, et al. Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors. World J Surg. 2012;36:1406\u201310.","journal-title":"World J Surg."},{"key":"4813_CR25","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1148\/radiol.2383042164","volume":"238","author":"MA Blake","year":"2006","unstructured":"Blake MA, Slattery JM, Kalra MK, Halpern EF, Fischman AJ, Mueller PR, Boland GW. Adrenal lesions: characterization with fused PET\/CT image in patients with proved or suspected malignancy\u2014initial experience. Radiology. 2006;238:970\u20137.","journal-title":"Radiology."},{"key":"4813_CR26","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2214\/AJR.08.1431","volume":"192","author":"GW Boland","year":"2009","unstructured":"Boland GW, Blake MA, Holalkere NS, Hahn PF. PET\/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. Am J Roentgenol. 2009;192:956\u201362.","journal-title":"AJR. Am J Roentgenol."},{"key":"4813_CR27","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2214\/AJR.11.8282","volume":"199","author":"D Ganeshan","year":"2012","unstructured":"Ganeshan D, Bhosale P, Kundra V. Current update on cytogenetics, taxonomy, diagnosis, and management of adrenocortical carcinoma: what radiologists should know. AJR. Am J Roentgenol. 2012;199:1283\u201393.","journal-title":"AJR. Am J Roentgenol."},{"key":"4813_CR28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1095-0397(99)00016-3","volume":"2","author":"SM Larson","year":"1999","unstructured":"Larson SM, Erdi Y, Akhurst T, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging. 1999;2:159\u201371.","journal-title":"Clin Positron Imaging."},{"key":"4813_CR29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00432-013-1545-7","volume":"140","author":"HW Chung","year":"2014","unstructured":"Chung HW, Lee KY, Kim HJ, Kim WS, So Y. FDG PET\/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma. J Cancer Res Clin Oncol. 2014;140:89\u201398.","journal-title":"J Cancer Res Clin Oncol."},{"key":"4813_CR30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00259-013-2528-2","volume":"41","author":"M Picchio","year":"2014","unstructured":"Picchio M, Kirienko M, Mapelli P, et al. Predictive value of pre-therapy (18)F-FDG PET\/CT for the outcome of (18)F-FDG PET-guided radiotherapy in patients with head and neck cancer. Eur J Nucl Med Mol Imaging. 2014;41:21\u201331.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"4813_CR31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1210\/jc.2012-2559","volume":"98","author":"I Erdogan","year":"2013","unstructured":"Erdogan I, Deutschbein T, Jurowich C, et al. The role of surgery in the management of recurrent adrenocortical carcinoma. J Clin Endocrinol Metab. 2013;98:181\u201391.","journal-title":"J Clin Endocrinol Metab."},{"key":"4813_CR32","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archsurg.136.5.543","volume":"136","author":"ML Kendrick","year":"2001","unstructured":"Kendrick ML, Lloyd R, Erickson L, et al. Adrenocortical carcinoma: surgical progress or status quo? Arch Surg. 2001;136:543\u20139.","journal-title":"Arch Surg."},{"key":"4813_CR33","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1677\/erc.1.01029","volume":"12","author":"DE Schteingart","year":"2005","unstructured":"Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M, Worden FP. Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer. 2005;12:667\u201380.","journal-title":"Endocr Relat Cancer."},{"key":"4813_CR34","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1530\/EJE-13-0519","volume":"169","author":"M Ayala-Ramirez","year":"2013","unstructured":"Ayala-Ramirez M, Jasim S, Feng L, et al. Adrenocortical carcinoma: clinical outcomes and prognosis of 330 patients at a tertiary care center. Eur J Endocrinol. 2013;169:891\u20139.","journal-title":"Eur J Endocrinol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-015-4813-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-015-4813-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-015-4813-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T07:22:08Z","timestamp":1559632928000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-015-4813-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,18]]},"references-count":34,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["4813"],"URL":"https:\/\/doi.org\/10.1245\/s10434-015-4813-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,18]]}}}